Article

ForbesForbes on 2022-01-25 00:38

FDA Rescinds Authorization For Covid Antibody Treatments By Regeneron, Eli Lilly

Monoclonal antibody treatments by Regeneron and Eli Lilly proved ineffective against the omicron variant, the FDA said.

Related news